Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer

dc.contributor.author	Lokuhetty, M D S
dc.contributor.author	Wijesinghe, Harshima D
dc.contributor.author	Damen, Johanna AAG
dc.contributor.author	Lee T, Teresa
dc.contributor.author	White, Valerie A
dc.contributor.author	Cree, Ian A
dc.date.accessioned	2021-03-11T12:16:55Z
dc.date.available	2021-03-11T12:16:55Z
dc.date.issued	2020
dc.identifier.citation	Lokuhetty MDS, Wijesinghe HD, Damen JAAG, Lee T, White VA, Cree IA, Indave BIciar. Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer. Cochrane Database of Systematic Reviews 2020, Issue 11. Art. No.: CD013784. DOI: 10.1002/14651858.CD013784.	en_US
dc.identifier.uri	http://archive.cmb.ac.lk:8080/xmlui/handle/70130/5126
dc.language.iso	en	en_US
dc.publisher	Wiley & Sons Ltd	en_US
dc.subject	Breast Cancer	en_US
dc.title	Prognostic value of the androgen receptor in addition to the established hormone receptors and HER2 status for predicting survival in women with early breast cancer	en_US
dc.type	Article	en_US